Explore Our Comprehensive Pharmaceuticals Industry Research Reports
P
2021
The global liver disease treatment market size was valued at $20,673.70 million in 2020, and is estimated to reach $36,455.70 million by 2030, growing at a CAGR of ...
Report Code : A00295 | Pages : 254 | Category : Life Sciences
U
2024
Chagas disease or American trypanosomiasis is a tropical parasitic disease caused by kinetoplastid protozoan parasite called Trypanosoma cruzi, which transmits the infectious disease to humans and animals.
Report Code : A05111 | Category : Life Sciences
P
2022
The global lysosomal disease treatment market was valued at $7.6 billion in 2021, and is projected to reach $14.1 billion by 2031, growing at a CAGR of 6.4% from 2022 to 2031.
Report Code : A05290 | Pages : 319 | Category : Life Sciences
P
2022
The global huntington's disease treatment market was valued at $315.2 million in 2021, and is projected to reach $707.5 million by 2031, growing at a CAGR of 8.4% from 2022 to 2031.
Report Code : A17522 | Pages : 301 | Category : Life Sciences
P
2022
In North America Lysosomal Disease Treatment Market segment, the End User segment is expected to register significant growth during the forecast period.
Report Code : A28010 | Category : Life Sciences
P
2022
The Mexico Lysosomal Disease Treatment Market report covers the drivers, restraints, and opportunities of the market. It focuses on the current market strategies adopted by the key players in the industry. The Mexico Lysosomal Disease Treatment Market report covers profile of leading stakeholders operating in the Mexico.
Report Code : A28011 | Category : Life Sciences
P
2022
End User segment is projected to be the dominating segment during the forecast period. The report offers an elaborate analysis on detailed impacts on the U.S. Lysosomal Disease Treatment Market due to the outbreak of COVID-19.
Report Code : A28012 | Category : Life Sciences
P
2022
The Canada Lysosomal Disease Treatment Market report covers the drivers, restraints, and opportunities of the market. It focuses on the current market strategies adopted by the key players in the industry. The Canada Lysosomal Disease Treatment Market report covers profile of leading stakeholders operating in the Canada.
Report Code : A28013 | Category : Life Sciences
P
2022
The current Europe Lysosomal Disease Treatment Market is quantitatively analyzed from 2021 to 2031 to benchmark the financial competency.
Report Code : A28014 | Category : Life Sciences
P
2022
In addition, it covers qualitative analysis on the basis of several parameters, including impact on market size, economic impact, regulatory framework, opportunity window, and key player strategies. End User was the leading segment.
Report Code : A28015 | Category : Life Sciences
Register and Earn 500 Loyalty Points
An Email Verification Code has been sent to your email address!
Please check your inbox and, if you don't find it there, also look in your junk folder.